Insight Molecular Diagnostics (IMDX) Goodwill & Intangibles (2020 - 2025)
Insight Molecular Diagnostics (IMDX) has disclosed Goodwill & Intangibles for 6 consecutive years, with $440000.0 as the latest value for Q4 2025.
- Quarterly Goodwill & Intangibles fell 96.99% to $440000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $440000.0 through Dec 2025, down 96.99% year-over-year, with the annual reading at $440000.0 for FY2025, 96.99% down from the prior year.
- Goodwill & Intangibles hit $440000.0 in Q4 2025 for Insight Molecular Diagnostics, roughly flat from $440000.0 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $117.9 million in Q2 2021 to a low of $440000.0 in Q4 2023.
- Historically, Goodwill & Intangibles has averaged $47.5 million across 5 years, with a median of $56.9 million in 2021.
- Biggest five-year swings in Goodwill & Intangibles: tumbled 99.38% in 2023 and later skyrocketed 3219.77% in 2024.
- Year by year, Goodwill & Intangibles stood at $80.6 million in 2021, then decreased by 11.4% to $71.4 million in 2022, then crashed by 99.38% to $440000.0 in 2023, then surged by 3219.77% to $14.6 million in 2024, then tumbled by 96.99% to $440000.0 in 2025.
- Business Quant data shows Goodwill & Intangibles for IMDX at $440000.0 in Q4 2025, $440000.0 in Q3 2025, and $440000.0 in Q2 2025.